Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Dec;36(12):e213.
doi: 10.2337/dc13-1134.

Comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125

Lotte Bjerre Knudsen  1 , Niels C Berg Nyborg, Claus Bo Svendsen, Niels Vrang, Alan C Moses
Affiliations
Comment

Comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125

Lotte Bjerre Knudsen et al. Diabetes Care. 2013 Dec.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Butler PC, Elashoff M, Elashoff R, Gale EAM. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118–2125 - PMC - PubMed
    1. Nyborg NC, Mølck AM, Madsen LW, Knudsen LB. The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species. Diabetes 2012;61:1243–1249 - PMC - PubMed
    1. Vrang N, Jelsing J, Simonsen L, et al. The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis. Am J Physiol Endocrinol Metab 2012;303:E253–E264 - PubMed
    1. Boyce JT, Boyce RW, Gundersen HJ. Choice of morphometric methods and consequences in the regulatory environment. Toxicol Pathol 2010;38:1128–1133 - PubMed
    1. Gore AC. Editorial: antibody validation requirements for articles published in endocrinology. Endocrinology 2013;154:579–580 - PubMed